Iron deficiency anaemia—an ongoing challenge [pdf-embedder url=”https://awgp.pt/wp-content/uploads/2022/11/Editorial-The-Lancet-22112022.pdf” title=”Editorial – The Lancet 22112022″]
[cmsmasters_row data_width=”boxed” data_padding_left=”3″ data_padding_right=”3″ data_top_style=”default” data_bot_style=”default” data_color=”default” data_bg_position=”top center” data_bg_repeat=”no-repeat” data_bg_attachment=”scroll” data_bg_size=”cover” data_bg_parallax_ratio=”0.5″ data_padding_top=”0″ data_padding_bottom=”50″][cmsmasters_column data_width=”1/1″][cmsmasters_text] Thrombocytosis and venous thromboembolism in cancer patients with chemotherapy induced anemia may be related to ESA induced iron restricted erythropoiesis and reversed by administration of IV iron David H. Henry,1* Naomi V. Dahl,2 and Michael A. Auerbach3 ...
